Facebook
Twitter
LinkedIn
Forward
2022 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of cancer patients. The course will review key evidence that forms the basis for current clinical practice guidelines and trends in new approaches. In addition, the course will cover implementation of hypofractionation in key disease sites as well as treatment of oligometastases and use of SBRT to improve outcomes for patients with metastatic disease.
Target Audience
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, attendees should be able to do the following:
- Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
- Safely utilize the latest radiation technologies to improve patient care.
- Incorporate hypofractionation into appropriate disease sites.
- Appropriately incorporate the treatment of oligometastases into clinical practice.
Name | Employment | Compensation/ Renumeration/Funding | Ownership/ Investment Interests | Leadership Positions |
Meena Bedi, MD | Medical College of Wisconsin | Varian: Speaker's Bureau | None | Medical College of Wisconsin: Sarcoma Director: Director of sarcoma team |
Julie Bradley, MD | University of Florida Proton Therapy Institute | Ion Beam Application: Travel Expenses: Relationship ended; Research grants: Research Grants | None | Medical Dosimetry Certification Board: Board Member: Relationship ended |
Russell Hales, MD | Johns Hopkins University | None | None | None |
Lara Hathout, MD, FRCPC | Rutgers Cancer Institute, New Brunswick, New Jersey Cervical Cancer | None | None | None |
Emma Holliday, MD | MD Anderson Cancer Center | ASCO: Honoraria: Relationship ended 01/22/2022; | None | None |
Theodore Hong, MD | Massachusetts General Hospital | Astra-Zenca: Research Grants | None | None |
Bradford Hoppe, MD, MPH | Mayo Clinic, Jacksonville, Florida | None | None | PTCOG-NA: Secretary |
Mitchel Kamrava, MD | Cedars-Sinai Cancer Institute, Los Angeles | None | None | ADROP: Board of Directors Member at Large |
David Palma, MD, PhD | London Health Sciences Centre/Ontario Institute for Cancer Research | None | None | None |
Murat Surucu, PhD | Stanford University | Reflexion Medical: Honoraria: Research Grants | None | None |
Rahul Tendulkar, MD | Cleveland Clinic Tassug Cancer Institute | Varian Medical Systems: Honoraria | None | None |
Mylin Torres, MD | Winship Cancer Institute, Emory University School of Medicine | BioAscend: Honoraria; | None | Winship Cancer Institute of Emory University: Co-Leader, Cancer Prevention & Control Research Program: Research Lead |
Phuoc Tran, MD | University of Maryland | AstraZeneca: Advisory Board: Relationship ended 09/11/2020 | Natsar Pharm: Royalty/ Patent | None |
Christina Tsien, MD | University of Maryland School of Medicine | Blue Earth: Honoraria: Relationship ended | None | None |
Sue Yom, MD | UCSF Bakar Precision Medicine Cancer Center/University of California, San Francisco | ASTRO: Honoraria | None | American Society for Radiation Oncology: Deputy Editor; |
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 18.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 18.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 18.00 Certificate of AttendanceThis activity was designated for 18.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
Nonmember: $500
Member: $375
Member-in-Training: $200
Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.”
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.